Body Contouring Devices Market Size, Share, Growth Analysis, By Product Type(Invasive Devices, Invasive Devices), By Application(Non Surgical Skin Resurfacing, Non Surgical Skin Tightening, Cellulite Treatment, Liposuction), By Region - Industry Forecast 2024-2031

Many of these firms are quickly choosing to expand geographically, collaborate strategically, and form alliances through mergers and acquisitions in developing and prosperous regions. Evolve Tone was certified by Health Canada and given to InMode Ltd. in June 2021. With this approval, Evolve platform will become Canada's only three distinct body remodelling technologies Tite, Trim, and Tone all in one hands-free device. The following are a few of the leading companies in the body-contouring device market.

Body Contouring Devices Market Top Player’s Company Profiles

• 3M Company
• Dentsply Sirona Inc.
• Danaher Corporation
• GC Corporation
• Ivoclar Vivadent AG
• Kuraray Noritake Dental Inc.
• Mitsui Chemicals, Inc.
• Patterson Companies, Inc.
• Septodont Holding
• Ultradent Products Inc.
• VOCO GmbH
• DMG Chemisch-Pharmazeutische Fabrik GmbH
• Henry Schein Inc.
• SHOFU Dental Corporation
• BISCO Inc.
• Coltene Holding AG
• DiaDent Group International
• FKG Dentaire SA
• Keystone Industries
• Premier Dental Products Company

Body Contouring Devices Market Recent Development

• In June 2021, people aged 18 and older who weighed more than 1.9 billion were overweight. Of these, nearly 650 million were obese; of people 18 and older, 39% were overweight and 13% were obese in the same year. The majority of people on Earth reside in nations where being overweight or obese kills more people than being underweight.
• In May 2021, Allergan aesthetic expanded the company's body contouring portfolio by announcing the acquisition of soliton and its newly launched RAP device.
• In May 2022, The EON Smarter Body Contouring device for noninvasive laser lipolysis of adipose tissue of the flanks introduced by Dominion Aesthetic Technologies received clearance from United States Food and Drug Administration clearance.
• In April 2022, VLCC announced the launch of a new non-invasive body contouring and slimming treatment in Oman, which uses United States Food and Drug Administration-approved laser technology to remove excess fat from the body without any surgical procedure.
• In May 2021, Allergan Aesthetics and Soliton announced an agreement under which Allergan Aesthetics will acquire Soliton and RESONICTM, its Rapid Acoustic Pulse device, the U.S. Food and Drug Administration (FDA) 510(k) approved is a non-invasive treatment for the short-term advancement in the appearance of cellulite. This acquisition will expand and complements Allergan Aesthetics' Body Contouring treatment portfolio, which includes CoolSculpting Elite